Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.
Financial Results:
- Jubilant Pharmova Ltd reported Revenues for Q2FY24 of ₹1,680.00 Crores up from ₹1,600.00 Crore year on year, a rise of 5.0%.
- Total Expenses for Q2FY24 of ₹1,601.00 Crores up from ₹1,520.00 Crores year on year, a rise of 5.33%.
- Consolidated Net Profit of ₹62.00 Crores up 1140.0% from ₹5.00 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹3.92, up 1,052.94% from ₹0.34 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.